Inflammasome animation.

Inflazome, a biotech company developing new drugs to block harmful inflammation, has secured further investment of $63 million.

28 November 2018
Melbourne housing

There has been another marked decline in the number of Australians migrating between cities and regions, while movement within capitals is on the rise.

22 May 2018